INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 143 filers reported holding INTRA CELLULAR THERAPIES INC in Q1 2020. The put-call ratio across all filers is 0.65 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $6,883,724 | +2.7% | 100,507 | +3.8% | 3.55% | +7.4% |
| Q1 2024 | $6,702,504 | -3.4% | 96,857 | 0.0% | 3.30% | -12.3% |
| Q4 2023 | $6,936,898 | +24.3% | 96,857 | -9.6% | 3.76% | +23.8% |
| Q3 2023 | $5,581,808 | -17.7% | 107,157 | 0.0% | 3.04% | -15.2% |
| Q2 2023 | $6,785,181 | +5.7% | 107,157 | -9.6% | 3.58% | -8.8% |
| Q1 2023 | $6,422,190 | -22.3% | 118,600 | -24.1% | 3.93% | -29.7% |
| Q4 2022 | $8,268,750 | +7.1% | 156,250 | -5.9% | 5.59% | +12.0% |
| Q3 2022 | $7,724,000 | -34.5% | 165,999 | -19.6% | 4.99% | -28.9% |
| Q2 2022 | $11,792,000 | -19.2% | 206,588 | -13.4% | 7.02% | +9.9% |
| Q1 2022 | $14,594,000 | -22.3% | 238,500 | -33.6% | 6.39% | -16.1% |
| Q4 2021 | $18,790,000 | +33.0% | 359,000 | -5.3% | 7.62% | +22.2% |
| Q3 2021 | $14,129,000 | -7.7% | 379,000 | +1.1% | 6.24% | +15.0% |
| Q2 2021 | $15,308,000 | +6.3% | 375,000 | -11.7% | 5.42% | -13.4% |
| Q1 2021 | $14,403,000 | +6.7% | 424,500 | 0.0% | 6.26% | +12.4% |
| Q4 2020 | $13,499,000 | +23.2% | 424,500 | -0.6% | 5.57% | -0.6% |
| Q3 2020 | $10,957,000 | +0.3% | 427,000 | +0.4% | 5.60% | -8.3% |
| Q2 2020 | $10,923,000 | +64.3% | 425,500 | -1.6% | 6.11% | +40.5% |
| Q1 2020 | $6,648,000 | -58.6% | 432,500 | -7.6% | 4.35% | -57.2% |
| Q4 2019 | $16,060,000 | – | 468,073 | – | 10.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DCF Advisers, LLC | 375,000 | $15,308,000 | 5.42% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 113,258 | $4,623,000 | 2.06% |
| Tri Locum Partners LP | 150,783 | $6,155,000 | 2.02% |
| COOPER/HAIMS ADVISORS, LLC | 61,116 | $2,495,000 | 1.64% |
| Vantage Consulting Group Inc | 226,670 | $9,252,000 | 1.61% |
| Nicholas Investment Partners, LP | 598,261 | $24,421,000 | 1.53% |
| Bellevue Group AG | 3,609,919 | $147,357,000 | 1.44% |
| GENERAL AMERICAN INVESTORS CO INC | 350,804 | $14,320,000 | 1.20% |
| Rhenman & Partners Asset Management AB | 429,728 | $17,541,000 | 1.19% |
| WASATCH ADVISORS LP | 6,506,789 | $265,607,000 | 1.08% |